 | • レポートコード：GIR-2104Z02213 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、生物学的医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。生物学的医薬品の種類別市場規模（フミラ、レミケード、リツキサン、エンブレル、ランタス、アバスチン、ハーセプチン、その他）、用途別市場規模（糖尿病、炎症、自己免疫疾患、血液疾患、循環器疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・生物学的医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Abbott Laboratories、Johnson & Johnson、Merck & Co.、Pfizer、Amgen、Sanofi、Novartis、Eli Lilly、Amgen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：フミラ、レミケード、リツキサン、エンブレル、ランタス、アバスチン、ハーセプチン、その他 ・用途別分析2016年-2026年：糖尿病、炎症、自己免疫疾患、血液疾患、循環器疾患、その他 ・生物学的医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・生物学的医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・生物学的医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・生物学的医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・生物学的医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Biologic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Biologic Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Biologic Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Biologic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Market segment by Application can be divided into
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
The key market players for global Biologic Drugs market are listed below:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Biologic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biologic Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Humira
1.2.3 Remicade
1.2.4 Rituxan
1.2.5 Enbrel
1.2.6 Lantus
1.2.7 Avastin
1.2.8 Herceptin
1.2.9 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biologic Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Diabetes
1.3.3 Inflammation
1.3.4 Auto-Immune Diseases
1.3.5 Blood Diseases
1.3.6 Cardiovascular Diseases
1.3.7 Others
1.4 Global Biologic Drugs Market Size & Forecast
1.4.1 Global Biologic Drugs Sales in Value (2016-2026))
1.4.2 Global Biologic Drugs Sales in Volume (2016-2026)
1.4.3 Global Biologic Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Biologic Drugs Production Capacity Analysis
1.5.1 Global Biologic Drugs Total Production Capacity (2016-2026)
1.5.2 Global Biologic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biologic Drugs Market Drivers
1.6.2 Biologic Drugs Market Restraints
1.6.3 Biologic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologic Drugs Product and Services
2.1.4 Roche Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Biologic Drugs Product and Services
2.2.4 Abbott Laboratories Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Biologic Drugs Product and Services
2.3.4 Johnson & Johnson Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Merck & Co.
2.4.1 Merck & Co. Details
2.4.2 Merck & Co. Major Business
2.4.3 Merck & Co. Biologic Drugs Product and Services
2.4.4 Merck & Co. Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Biologic Drugs Product and Services
2.5.4 Pfizer Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Biologic Drugs Product and Services
2.6.4 Amgen Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Biologic Drugs Product and Services
2.7.4 Sanofi Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Biologic Drugs Product and Services
2.8.4 Novartis Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Biologic Drugs Product and Services
2.9.4 Eli Lilly Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Biologic Drugs Product and Services
2.10.4 Amgen Biologic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Biologic Drugs Sales by Manufacturer
3.1 Global Biologic Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Biologic Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Biologic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Biologic Drugs Manufacturer Market Share
3.4.2 Top 6 Biologic Drugs Manufacturer Market Share
3.5 Global Biologic Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Biologic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biologic Drugs Market Size by Region
4.1.1 Global Biologic Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Biologic Drugs Revenue by Region (2016-2026)
4.2 North America Biologic Drugs Revenue (2016-2026)
4.3 Europe Biologic Drugs Revenue (2016-2026)
4.4 Asia-Pacific Biologic Drugs Revenue (2016-2026)
4.5 South America Biologic Drugs Revenue (2016-2026)
4.6 Middle East and Africa Biologic Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Biologic Drugs Sales in Volume by Type (2016-2026)
5.2 Global Biologic Drugs Revenue by Type (2016-2026)
5.3 Global Biologic Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Biologic Drugs Sales in Volume by Application (2016-2026)
6.2 Global Biologic Drugs Revenue by Application (2016-2026)
6.3 Global Biologic Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Biologic Drugs Sales by Type (2016-2026)
7.2 North America Biologic Drugs Sales by Application (2016-2026)
7.3 North America Biologic Drugs Market Size by Country
7.3.1 North America Biologic Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Biologic Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Biologic Drugs Sales by Type (2016-2026)
8.2 Europe Biologic Drugs Sales by Application (2016-2026)
8.3 Europe Biologic Drugs Market Size by Country
8.3.1 Europe Biologic Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Biologic Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Biologic Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Biologic Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Biologic Drugs Market Size by Region
9.3.1 Asia-Pacific Biologic Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Biologic Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Biologic Drugs Sales by Type (2016-2026)
10.2 South America Biologic Drugs Sales by Application (2016-2026)
10.3 South America Biologic Drugs Market Size by Country
10.3.1 South America Biologic Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Biologic Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biologic Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Biologic Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Biologic Drugs Market Size by Country
11.3.1 Middle East & Africa Biologic Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Biologic Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Biologic Drugs Typical Distributors
12.3 Biologic Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Biologic Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Biologic Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Biologic Drugs Product and Services
Table 6. Roche Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Major Business
Table 9. Abbott Laboratories Biologic Drugs Product and Services
Table 10. Abbott Laboratories Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Biologic Drugs Product and Services
Table 14. Johnson & Johnson Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 16. Merck & Co. Major Business
Table 17. Merck & Co. Biologic Drugs Product and Services
Table 18. Merck & Co. Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Biologic Drugs Product and Services
Table 22. Pfizer Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Amgen Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Major Business
Table 25. Amgen Biologic Drugs Product and Services
Table 26. Amgen Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Biologic Drugs Product and Services
Table 30. Sanofi Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Biologic Drugs Product and Services
Table 34. Novartis Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Biologic Drugs Product and Services
Table 38. Eli Lilly Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Amgen Basic Information, Manufacturing Base and Competitors
Table 40. Amgen Major Business
Table 41. Amgen Biologic Drugs Product and Services
Table 42. Amgen Biologic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Biologic Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Biologic Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Biologic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Biologic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Biologic Drugs Production Site of Key Manufacturer
Table 48. Global Biologic Drugs Sales by Region (2016-2021e) & (K Units)
Table 49. Global Biologic Drugs Sales by Region (2021-2026) & (K Units)
Table 50. Global Biologic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Biologic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Biologic Drugs Sales by Type (2016-2021e) & (K Units)
Table 53. Global Biologic Drugs Sales by Type (2021-2026) & (K Units)
Table 54. Global Biologic Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Biologic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Biologic Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Biologic Drugs Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Biologic Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. Global Biologic Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Global Biologic Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Biologic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Biologic Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Biologic Drugs Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Biologic Drugs Sales by Country (2016-2021e) & (K Units)
Table 65. North America Biologic Drugs Sales by Country (2021-2026) & (K Units)
Table 66. North America Biologic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Biologic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Biologic Drugs Sales by Type (2016-2021e) & (K Units)
Table 69. North America Biologic Drugs Sales by Type (2021-2026) & (K Units)
Table 70. North America Biologic Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. North America Biologic Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Europe Biologic Drugs Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Biologic Drugs Sales by Country (2021-2026) & (K Units)
Table 74. Europe Biologic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Biologic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Biologic Drugs Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Biologic Drugs Sales by Type (2021-2026) & (K Units)
Table 78. Europe Biologic Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Biologic Drugs Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Biologic Drugs Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Biologic Drugs Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Biologic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Biologic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Biologic Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Biologic Drugs Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Biologic Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Biologic Drugs Sales by Application (2021-2026) & (K Units)
Table 88. South America Biologic Drugs Sales by Country (2016-2021e) & (K Units)
Table 89. South America Biologic Drugs Sales by Country (2021-2026) & (K Units)
Table 90. South America Biologic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Biologic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Biologic Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. South America Biologic Drugs Sales by Type (2021-2026) & (K Units)
Table 94. South America Biologic Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. South America Biologic Drugs Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Biologic Drugs Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Biologic Drugs Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Biologic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Biologic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Biologic Drugs Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Biologic Drugs Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Biologic Drugs Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Biologic Drugs Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Biologic Drugs Typical Distributors
Table 107. Biologic Drugs Typical Customers
List of Figures
Figure 1. Biologic Drugs Picture
Figure 2. Global Biologic Drugs Sales Market Share by Type in 2020
Figure 3. Humira
Figure 4. Remicade
Figure 5. Rituxan
Figure 6. Enbrel
Figure 7. Lantus
Figure 8. Avastin
Figure 9. Herceptin
Figure 10. Others
Figure 11. Global Biologic Drugs Sales Market Share by Application in 2020
Figure 12. Diabetes
Figure 13. Inflammation
Figure 14. Auto-Immune Diseases
Figure 15. Blood Diseases
Figure 16. Cardiovascular Diseases
Figure 17. Others
Figure 18. Global Biologic Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 19. Global Biologic Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 20. United States Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Canada Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Mexico Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Germany Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. France Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. United Kingdom Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Russia Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Italy Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. China Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Japan Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Korea Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. India Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Southeast Asia Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Australia Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Brazil Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Egypt Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Saudi Arabia Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. South Africa Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Turkey Biologic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Global Biologic Drugs Sales (2016-2026) & (K Units)
Figure 40. Global Biologic Drugs Production Capacity (2016-2026) & (K Units)
Figure 41. Global Biologic Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 42. Biologic Drugs Market Drivers
Figure 43. Biologic Drugs Market Restraints
Figure 44. Biologic Drugs Market Trends
Figure 45. Global Biologic Drugs Sales Market Share by Manufacturer in 2020
Figure 46. Global Biologic Drugs Revenue Market Share by Manufacturer in 2020
Figure 47. Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 48. Top 3 Biologic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 49. Top 6 Biologic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 50. Global Biologic Drugs Sales Market Share by Region (2016-2026)
Figure 51. Global Biologic Drugs Revenue Market Share by Region (2016-2026)
Figure 52. North America Biologic Drugs Revenue (2016-2026) & (USD Million)
Figure 53. Europe Biologic Drugs Revenue (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Biologic Drugs Revenue (2016-2026) & (USD Million)
Figure 55. South America Biologic Drugs Revenue (2016-2026) & (USD Million)
Figure 56. Middle East & Africa Biologic Drugs Revenue (2016-2026) & (USD Million)
Figure 57. Global Biologic Drugs Sales Market Share by Type (2016-2026)
Figure 58. Global Biologic Drugs Revenue Market Share by Type (2016-2026)
Figure 59. Global Biologic Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 60. Global Biologic Drugs Sales Market Share by Application (2016-2026)
Figure 61. Global Biologic Drugs Revenue Market Share by Application (2016-2026)
Figure 62. Global Biologic Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 63. North America Biologic Drugs Sales Market Share by Country (2016-2026)
Figure 64. North America Biologic Drugs Revenue Market Share by Country (2016-2026)
Figure 65. North America Biologic Drugs Sales Market Share by Type (2016-2026)
Figure 66. North America Biologic Drugs Sales Market Share by Application (2016-2026)
Figure 67. Europe Biologic Drugs Sales Market Share by Country (2016-2026)
Figure 68. Europe Biologic Drugs Revenue Market Share by Country (2016-2026)
Figure 69. Europe Biologic Drugs Sales Market Share by Type (2016-2026)
Figure 70. Europe Biologic Drugs Sales Market Share by Application (2016-2026)
Figure 71. Asia-Pacific Biologic Drugs Sales Market Share by Region (2016-2026)
Figure 72. Asia-Pacific Biologic Drugs Revenue Market Share by Region (2016-2026)
Figure 73. Asia-Pacific Biologic Drugs Sales Market Share by Region (2016-2026)
Figure 74. Asia-Pacific Biologic Drugs Sales Market Share by Application (2016-2026)
Figure 75. South America Biologic Drugs Sales Market Share by Country (2016-2026)
Figure 76. South America Biologic Drugs Revenue Market Share by Country (2016-2026)
Figure 77. South America Biologic Drugs Sales Market Share by Type (2016-2026)
Figure 78. South America Biologic Drugs Sales Market Share by Application (2016-2026)
Figure 79. Middle East & Africa Biologic Drugs Sales Market Share by Country (2016-2026)
Figure 80. Middle East & Africa Biologic Drugs Revenue Market Share by Country (2016-2026)
Figure 81. Middle East & Africa Biologic Drugs Sales Market Share by Type (2016-2026)
Figure 82. Middle East & Africa Biologic Drugs Sales Market Share by Application (2016-2026)
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
世界の生物学的治療市場規模・現状・予測（2021年-2027年） Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…- 世界の慢性閉塞性肺疾患（COPD）治療薬市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a chronic bronchitis and/or emphysema characterized by airflow obstruction, which can further develop into a common chronic disease of cor pulmona and respiratory failure.It is related to the abnormal inflammatory reaction of harmful gases and harmful …
- 世界の生物学における使い捨て技術市場規模・現状・予測（2021年-2027年） Single-use technologies are widely used in the biotherapeutic market to reduce risk and improve operational efficiencies. Rising awareness about therapeutic applications of biotherapeutics is a key driver for the global single-use technologies market. Market Analysis and Insights: Global Single-Use …
- 世界の生物学における使い捨て技術市場規模・現状・予測（2021年-2027年） Single-use technologies are widely used in the biotherapeutic market to reduce risk and improve operational efficiencies. Rising awareness about therapeutic applications of biotherapeutics is a key driver for the global single-use technologies market. Market Analysis and Insights: Global Single-Use …
- 世界の生物学的治療薬市場規模・現状・予測（2021年-2027年） Biologic Therapeutic Drug are used for treatment of numerous diseases and conditions, and are the most advanced therapies. Market Analysis and Insights: Global Biologic Therapeutic Drug Market The global Biologic Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX …